Is NAD+ a peptide? no, and here’s why clinics sell it like one

No, NAD+ is not a peptide. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme made of two nucleotides joined through their phosphate groups, and it contains no amino acids, while a peptide is by definition a chain of amino acids. Clinics sell it beside peptides because it comes in the same vials and nasal sprays from the same compounding pharmacies, and because, unlike most peptides marketed online, a licensed pharmacy may lawfully compound it. This guide explains the chemistry in plain terms, why the two get bundled, what the human studies of injected NAD+ measured and how NAD+ injections are prescribed.

What makes something a peptide

Peptides and proteins are built from amino acids. In its 2020 rule defining “biological product”, the FDA noted that the terms protein, polypeptide and peptide “refer to amino acid polymers” made of alpha amino acids “linked by peptide bonds” (Federal Register). The same rule draws the line by length: a chain of more than 40 amino acids with a defined sequence is a protein, regulated as a biologic. Shorter chains are peptides, regulated as drugs. Sermorelin (29 amino acids), BPC-157 (15) and GHK-Cu (3) are all peptides. Our guide to what peptides are covers the rest.

What NAD+ is

NAD+ belongs to a different family of molecules. PubChem, the chemistry database run by the National Institutes of Health, describes it as “a dinucleotide of adenine and nicotinamide” with “coenzyme activity in redox reactions” (PubChem). Each half is a nucleotide: a base (adenine on one side, nicotinamide on the other) attached to a ribose sugar and a phosphate group. The two halves are joined phosphate to phosphate.

In the body, NAD+ works as a helper molecule for enzymes. It carries electrons in the reactions that turn food into usable energy, switching between NAD+ and its reduced form, NADH, and it donates parts of itself to enzymes that regulate DNA repair, metabolism and immune function. Your cells make it from the amino acid tryptophan, from vitamin B3 (niacin) and from related compounds such as nicotinamide, nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) (Reyna et al.). Those precursors are sold as supplements; our guide to NMN vs NAD+ compares them.

One wrinkle explains some of the confusion: the body makes NAD+ partly from tryptophan, which is an amino acid. Being made from an amino acid doesn’t make a molecule a peptide, any more than vitamin B3 does.

Why clinics sell NAD+ next to peptides

If NAD+ isn’t a peptide, why does it show up on so many peptide menus? Four practical reasons:

• Same format. Clinics sell NAD+ as vials you inject under the skin and as nasal sprays, the same forms they use for sermorelin and PT-141. Some list it on the same treatment page as sermorelin; RxSpan MD prices both on its longevity page.
• Same pharmacies. NAD+ and the lawful peptides are all made by 503A compounding pharmacies for an individual prescription.
• Same pitch. NAD+ is sold for energy and healthy aging, the same longevity story that surrounds many peptides.
• It can be compounded. The FDA lists NAD in Category 1 of its 503A list, so a pharmacy may make it. Many of the peptides that dominate searches, including BPC-157, TB-500, KPV and MOTS-c, sit in no category and can’t be compounded at all (FDA). NAD+ fills part of that gap on a clinic’s menu.

NAD+ peptide benefits: what the human studies measured

Clinics promote NAD+ injections and drips for energy, focus and healthy aging. The published human studies of NAD+ given directly into the body are small and measured blood chemistry and tolerability, not those outcomes:

• Grant et al., 2019. Eight healthy men aged 30 to 55 received 750 mg of NAD+ by IV over 6 hours, and researchers measured NAD+ and its breakdown products in blood and urine over 8 hours (Frontiers in Aging Neuroscience). NAD+ levels in the blood did not rise for the first 2 hours of the drip.
• Reyna et al., 2026. A review of records from a commercial wellness clinic compared 6 clients who received 500 mg of IV NAD+ on 4 days in a row with 8 who received IV nicotinamide riboside, following them for 30 days (Frontiers in Aging). It measured symptoms, infusion time, blood pressure, heart rate and blood markers. All 6 NAD+ clients reported moderate to severe symptoms during the infusions, including cramping, nausea, vomiting, a faster heart rate and chest pressure, which resolved when the drips ended. Their infusions averaged 97 minutes.

The 2026 authors wrote that clinics increasingly offer IV NAD+ “despite limited evaluation of safety and effectiveness”. Our guides to NAD+ therapy and NAD+ side effects go through the evidence form by form.

NAD peptide injection: how it is lawfully prescribed

NAD+ is not FDA-approved for any use, and there is no approved NAD+ drug. It can still be prescribed lawfully, through compounding:

1. A licensed clinician reviews your history and writes a prescription.
2. A state-licensed 503A pharmacy compounds NAD+ for you, as an injection or nasal spray.
3. The pharmacy must use NAD from an FDA-registered manufacturer, with a valid certificate of analysis (FDA).

This works because NAD sits in Category 1 of the FDA’s list of substances nominated for 503A compounding, most recently updated May 14, 2026 (FDA). Category 1 is an interim policy: the FDA does not intend to take action against pharmacies compounding with those substances while it decides whether to add them to its final 503A bulks list. That is enforcement discretion, not approval, and it could end if the FDA decides against NAD. The reduced form, NADH disodium, is also in Category 1. One salt, beta-nicotinamide adenine dinucleotide disodium salt trihydrate, is in Category 3, which isn’t covered, so it’s reasonable to ask a pharmacy which form it uses.

Prices vary with the vial size, the plan length and whether a membership is billed on top. As of October 2026, RxSpan MD charges $150 a month for NAD+ injections on a prepaid 12-month plan, or $249 month to month, with the consult, medication, supplies and shipping included; yourEra lists NAD+ therapy from $170 a month; and Eden charges $186 a month for the medication on a 3-month plan, plus a separate membership. Our NAD+ provider rankings and NAD+ nasal spray rankings compare the clinics we list, and the NAD+ treatment page has the drug facts in one place.

NAD plus peptide combinations

Many clinics sell NAD+ alongside peptides, and some offer them as a package. Each item in a package has its own legal status, and NAD+ being lawful to compound says nothing about the rest:

NAD+ being lawful to compound doesn’t make a peptide sold with it lawful. Ask which pharmacy fills each item, and check our peptide legal status guide for anything not listed here.

The bottom line

NAD+ is a coenzyme made of two nucleotides, not a chain of amino acids, so it isn’t a peptide. Clinics sell it with peptides because it comes in the same vials and sprays, from the same pharmacies, with the same longevity pitch, and because it is in the FDA’s Category 1, which lets a licensed pharmacy compound it. That status is not FDA approval, and the human studies of injected NAD+ are small and measured tolerability and blood levels rather than benefits. If you’re considering it, see the longevity hub, talk it through with a licensed clinician, and choose a clinic that states its full price and names its pharmacy.